Antioxidant effects of resveratrol and other stilbene derivatives on oxidative stress and NO bioavailability: Potential benefits to cardiovascular diseases

Biochimie

Volumn 94, Issue 2, 2012, Pages 269-276

  Frombaum, Matthieu ^a   Le Clanche, Solenn ^a   Bonnefont Rousselot, Dominique ^a,b   Borderie, Didier ^a,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Hôpital Cochin APHP ^*  (France)

Author keywords

Cardiovascular disease; Endothelial dysfunction; Nitric oxide; Oxidative stress; Resveratrol

Indexed keywords

ARGININE; ARGININOSUCCINATE LYASE; ARGININOSUCCINATE SYNTHASE; COLLAGEN; DIMETHYLARGININASE; ESTRADIOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; MELATONIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PICEATANNOL; PROBUCOL; RESVERATROL; STILBENE DERIVATIVE; TAURINE;

ANTIHYPERTENSIVE THERAPY; ANTIOXIDANT ACTIVITY; ARTERY ENDOTHELIUM; ATHEROSCLEROSIS; BIOAVAILABILITY; CARDIOVASCULAR RISK; CATALYSIS; CELL PROLIFERATION; COMPETITIVE INHIBITION; DIABETES MELLITUS; DIET; DRUG BLOOD LEVEL; ENZYME ACTIVE SITE; GLUCOSE HOMEOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN RELEASE; METABOLIC SYNDROME X; NONHUMAN; OXIDATIVE STRESS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN HYDROLYSIS; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; PROTEIN TARGETING; REVIEW; RISK BENEFIT ANALYSIS; UPREGULATION;

ANIMALS; ANTIOXIDANTS; ARGININE; BIOLOGICAL AVAILABILITY; CARDIOVASCULAR DISEASES; DIET, ATHEROGENIC; ENDOTHELIUM, VASCULAR; FATTY ACIDS; HUMANS; MICE; NITRIC OXIDE; OXIDATIVE STRESS; POLYPHENOLS; RABBITS; RATS; REACTIVE OXYGEN SPECIES; STILBENES; WINE;

EID: 84855848241     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2011.11.001     Document Type: Review

References (85)

1. K. Tziomalos, V.G. Athyros, A. Karagiannis, and D.P. Mikhailidis Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management, nutrition Metab. Cardiovasc. Dis. 20 2010 140 146
2. C. Napoli, F. de Nigris, S. Williams-Ignarro, O. Pignalosa, V. Sica, and L.J. Ignarro Nitric oxide and atherosclerosis: an update Nitric Oxide 15 2006 265 279 (Pubitemid 44649284)
3. M. Frombaum, P. Therond, R. Djelidi, J.-L. Beaudeux, D. Bonnefont-Rousselot, and D. Borderie Piceatannol is more effective than resveratrol in restoring endothelial cell dimethylarginine dimethylaminohydrolase expression and activity after high-glucose oxidative stress Free Radic. Res. 45 2011 293 302
4. C.A. Schmitt, E.H. Heiss, and V.M. Dirsch Effect of resveratrol on endothelial cell function: molecular mechanisms Biofactors 36 2010 342 349
5. Y.-L. Tain, L.-T. Huang, I.-C. Lin, Y.-T. Lau, and C.-Y. Lin Melatonin prevents hypertension and increased asymmetric dimethylarginine in young spontaneous hypertensive rats J. Pineal Res. 49 2010 390 398
6. B. Tan, D.-J. Jiang, H. Huang, S.-J. Jia, J.-L. Jiang, and C.-P. Hu Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway Vascul. Pharmacol. 46 2007 338 345 (Pubitemid 46386501)
7. A. Csiszar Anti-inflammatory effects of resveratrol: possible role in prevention of age-related cardiovascular disease Ann. N. Y. Acad. Sci. 1215 2011 117 122
8. B.R. Flam, D.C. Eichler, and L.P. Solomonson Endothelial nitric oxide production is tightly coupled to the citrulline-NO cycle Nitric Oxide 17 2007 115 121 (Pubitemid 47513850)
9. S. Oyadomari, T. Gotoh, K. Aoyagi, E. Araki, M. Shichiri, and M. Mori Coinduction of endothelial nitric oxide synthase and arginine recycling enzymes in aorta of diabetic rats Nitric Oxide 5 2001 252 260 (Pubitemid 32553596)
10. H. Nagasaka, H. Tsukahara, T. Yorifuji, T. Miida, K. Murayama, and T. Tsuruoka Evaluation of endogenous nitric oxide synthesis in congenital urea cycle enzyme defects Metab. Clin. Exp. 58 2009 278 282
11. M.U. Latasa, M.V. Carretero, E.R. García-Trevijano, L. Torres, J.M. Mato, and M.A. Avila Identification of argininosuccinate lyase as a hypoxia-responsive gene in rat hepatocytes J. Hepatol. 33 2000 709 715
12. M. Mori Regulation of nitric oxide synthesis and apoptosis by arginase and arginine recycling J. Nutr. 137 2007 1616S 1620S (Pubitemid 46855520)
13. S. Ryoo, C.A. Lemmon, K.G. Soucy, G. Gupta, A.R. White, and D. Nyhan Oxidized low-density lipoprotein-dependent endothelial arginase II activation contributes to impaired nitric oxide signaling Circ. Res. 99 2006 951 960 (Pubitemid 44657798)
14. V. Bronte, and P. Zanovello Regulation of immune responses by L-arginine metabolism Nat. Rev. Immunol. 5 2005 641 654 (Pubitemid 41113195)
15. H. Maarsingh, J. Zaagsma, and H. Meurs Arginine homeostasis in allergic asthma Eur. J. Pharmacol. 585 2008 375 384
16. P.C. Rodríguez, and A.C. Ochoa Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives Immunol. Rev. 222 2008 180 191 (Pubitemid 351430370)
17. G.V. Marinova, R.Y. Loyaga-Rendon, S. Obayashi, T. Ishibashi, T. Kubota, and M. Imamura Possible involvement of altered arginase activity, arginase type I and type II expressions, and nitric oxide production in occurrence of intimal hyperplasia in premenopausal human uterine arteries J. Pharmacol. Sci. 106 2008 385 393 (Pubitemid 351468591)
18. X. Gao, X. Xu, S. Belmadani, Y. Park, Z. Tang, and A.M. Feldman TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury Arterioscler. Thromb. Vasc. Biol. 27 2007 1269 1275 (Pubitemid 46809414)
19. W. Zhu, U.M. Chandrasekharan, S. Bandyopadhyay, S.M. Morris Jr. , P.E. DiCorleto, and V.S. Kashyap Thrombin induces endothelial arginase through AP-1 activation Am. J. Physiol. Cell Physiol. 298 2010 C952 C960
20. M.J. Romero, D.H. Platt, H.E. Tawfik, M. Labazi, A.B. El-Remessy, and M. Bartoli Diabetes-induced coronary vascular dysfunction involves increased arginase activity Circ. Res. 102 2008 95 102
21. N.N. Huynh, E.E. Harris, J.F.P. Chin-Dusting, and K.L. Andrews The vascular effects of different arginase inhibitors in rat isolated aorta and mesenteric arteries Br. J. Pharmacol. 156 2009 84 93
22. A. Woo, B. Min, and S. Ryoo Piceatannol-3'-O-beta-D-glucopyranoside as an active component of rhubarb activates endothelial nitric oxide synthase through inhibition of arginase activity Exp. Mol. Med. 42 2010 524 532
23. S. Pal, S.N. Vishwanath, H. Erdjument-Bromage, P. Tempst, and S. Sif Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes Mol. Cell. Biol. 24 2004 9630 9645 (Pubitemid 39391698)
24. F.-M. Boisvert, C.A. Chénard, and S. Richard Protein interfaces in signaling regulated by arginine methylation Sci. STKE 2005 2005 re2
25. M.T. Bedford, and S. Richard Arginine methylation an emerging regulator of protein function Mol. Cell. 18 2005 263 272 (Pubitemid 41350532)
26. D.B. Seligson, S. Horvath, T. Shi, H. Yu, S. Tze, and M. Grunstein Global histone modification patterns predict risk of prostate cancer recurrence Nature 435 2005 1262 1266 (Pubitemid 40943093)
27. R.H. Böger Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond Ann. Med. 38 2006 126 136
28. T. Teerlink, Z. Luo, F. Palm, and C.S. Wilcox Cellular ADMA: regulation and action Pharmacol. Res. 60 2009 448 460
29. S. Shin, S. Mohan, and H.-L. Fung Intracellular l-arginine concentration does not determine NO production in endothelial cells: implications on the "l-arginine paradox" Biochem. Biophysical Res. Commun. 2011
30. M. Anderssohn, E. Schwedhelm, N. Lüneburg, R.S. Vasan, and R.H. Böger Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus Diab. Vasc. Dis. Res. 7 2010 105 118
31. E. Schwedhelm, and R.H. Böger The role of asymmetric and symmetric dimethylarginines in renal disease Nat. Rev. Nephrol. 7 2011 275 285
32. F. Palm, M.L. Onozato, Z. Luo, and C.S. Wilcox Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems Am. J. Physiol. Heart Circ. Physiol. 293 2007 H3227 H3245
33. J. Murray-Rust, J. Leiper, M. McAlister, J. Phelan, S. Tilley, and J. Santa Maria Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase Nat. Struct. Biol. 8 2001 679 683 (Pubitemid 32757926)
34. S.-J. Jia, D.-J. Jiang, C.-P. Hu, X.-H. Zhang, H.-W. Deng, and Y.-J. Li Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells Vascul. Pharmacol. 44 2006 143 148 (Pubitemid 43183662)
35. H.-Y. Xin, D.-J. Jiang, S.-J. Jia, K. Song, G.-P. Wang, and Y.-J. Li Regulation by DDAH/ADMA pathway of lipopolysaccharide-induced tissue factor expression in endothelial cells Thromb. Haemost. 97 2007 830 838 (Pubitemid 46779968)
36. V. Sorrenti, F. Mazza, A. Campisi, L. Vanella, G. Li Volti, and C. Di Giacomo High glucose-mediated imbalance of nitric oxide synthase and dimethylarginine dimethylaminohydrolase expression in endothelial cells Curr. Neurovasc. Res. 3 2006 49 54
37. Q.-F. Yin, S.-H. Fu, P. He, and Y. Xiong Dimethylarginine dimethylaminohydrolase inhibition and asymmetric dimethylarginine accumulation contribute to endothelial dysfunction in rats exposed to glycosylated protein: effects of aminoguanidine Atherosclerosis 190 2007 53 61 (Pubitemid 44908321)
38. A. Ito, P.S. Tsao, S. Adimoolam, M. Kimoto, T. Ogawa, and J.P. Cooke Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase Circulation 99 1999 3092 3095 (Pubitemid 29289071)
39. Z. Luo, T. Teerlink, K. Griendling, S. Aslam, W.J. Welch, and C.S. Wilcox Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cells Hypertension 56 2010 498 504
40. J. Leiper, J. Murray-Rust, N. McDonald, and P. Vallance S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase Proc. Natl. Acad. Sci. U.S.A. 99 2002 13527 13532 (Pubitemid 35215415)
41. J.-L. Jiang, X.-H. Zhang, N.-S. Li, W.-Q. Rang, Feng-Ye, and C.-P. Hu Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity Cardiovasc. Drugs Ther. 20 2006 281 294 (Pubitemid 44701162)
42. Q.-F. Yin, and Y. Xiong Pravastatin restores DDAH activity and endothelium-dependent relaxation of rat aorta after exposure to glycated protein J. Cardiovasc. Pharmacol. 45 2005 525 532 (Pubitemid 40734572)
43. D.P. Holden, J.E. Cartwright, S.S. Nussey, and G.S.J. Whitley Estrogen stimulates dimethylarginine dimethylaminohydrolase activity and the metabolism of asymmetric dimethylarginine Circulation 108 2003 1575 1580 (Pubitemid 37187783)
44. P. Lorenz, S. Roychowdhury, M. Engelmann, G. Wolf, and T.F.W. Horn Oxyresveratrol and resveratrol are potent antioxidants and free radical scavengers: effect on nitrosative and oxidative stress derived from microglial cells Nitric Oxide 9 2003 64 76 (Pubitemid 37386375)
45. Y. Rhayem, P. Thérond, L. Camont, M. Couturier, J.-L. Beaudeux, and A. Legrand Chain-breaking activity of resveratrol and piceatannol in a linoleate micellar model Chem. Phys. Lipids 155 2008 48 56
46. J. Zheng, and V.D. Ramirez Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals Br. J. Pharmacol. 130 2000 1115 1123 (Pubitemid 30453547)
47. L.M. Hung, J.K. Chen, R.S. Lee, H.C. Liang, and M.J. Su Beneficial effects of astringinin, a resveratrol analogue, on the ischemia and reperfusion damage in rat heart Free Radic. Biol. Med. 30 2001 877 883
48. Q. Yuan, J. Peng, S.-Y. Liu, C.-J. Wang, D.-X. Xiang, and X.-M. Xiong Inhibitory effect of resveratrol derivative BTM-0512 on high glucose-induced cell senescence involves dimethylaminohydrolase/asymmetric dimethylarginine pathway Clin. Exp. Pharmacol. Physiol. 37 2010 630 635
49. V. Achan, C.T.L. Tran, F. Arrigoni, G.S.J. Whitley, J.M. Leiper, and P. Vallance all-trans-Retinoic acid increases nitric oxide synthesis by endothelial cells: a role for the induction of dimethylarginine dimethylaminohydrolase Circ. Res. 90 2002 764 769 (Pubitemid 34633891)
50. C.-W. Lu, Y. Xiong, and P. He Dimethylarginine dimethylaminohydrolase-2 overexpression improves impaired nitric oxide synthesis of endothelial cells induced by glycated protein Nitric Oxide 16 2007 94 103 (Pubitemid 44820889)
51. J. Leiper, M. Nandi, B. Torondel, J. Murray-Rust, M. Malaki, and B. O'Hara Disruption of methylarginine metabolism impairs vascular homeostasis Nat. Med. 13 2007 198 203
52. H. Dayoub, V. Achan, S. Adimoolam, J. Jacobi, M.C. Stuehlinger, and B. -yin Wang Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence Circulation 108 2003 3042 3047 (Pubitemid 37553576)
53. M.J. Crabtree, C.L. Smith, G. Lam, M.S. Goligorsky, and S.S. Gross Ratio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs. superoxide production by eNOS Am. J. Physiol. Heart Circ. Physiol. 294 2008 H1530 H1540
54. R. Heller, A. Unbehaun, B. Schellenberg, B. Mayer, G. Werner-Felmayer, and E.R. Werner L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin J. Biol. Chem. 276 2001 40 47 (Pubitemid 32050286)
55. Y. Higashi, S. Sasaki, K. Nakagawa, Y. Fukuda, H. Matsuura, and T. Oshima Tetrahydrobiopterin enhances forearm vascular response to acetylcholine in both normotensive and hypertensive individuals Am. J. Hypertens. 15 2002 326 332 (Pubitemid 34408972)
56. E. Stroes, J. Kastelein, F. Cosentino, W. Erkelens, R. Wever, and H. Koomans Tetrahydrobiopterin restores endothelial function in hypercholesterolemia J. Clin. Invest. 99 1997 41 46 (Pubitemid 27058292)
57. T. Heitzer, K. Krohn, S. Albers, and T. Meinertz Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with type II diabetes mellitus Diabetologia 43 2000 1435 1438
58. S.J. Moat, Z.L. Clarke, A.K. Madhavan, M.J. Lewis, and D. Lang Folic acid reverses endothelial dysfunction induced by inhibition of tetrahydrobiopterin biosynthesis Eur. J. Pharmacol. 530 2006 250 258 (Pubitemid 43075496)
59. 2- imbalance in insulin-resistant rat aorta Diabetes 48 1999 2437 2445 (Pubitemid 30395437)
60. K. Sydow, and T. Münzel ADMA and oxidative stress Atheroscler. Suppl. 4 2003 41 51 (Pubitemid 38234494)
61. A. Warnholtz, G. Nickenig, E. Schulz, R. Macharzina, J.H. Bräsen, and M. Skatchkov Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system Circulation 99 1999 2027 2033 (Pubitemid 29183901)
62. T. Wallerath, G. Deckert, T. Ternes, H. Anderson, H. Li, and K. Witte Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase Circulation 106 2002 1652 1658
63. G. Spanier, H. Xu, N. Xia, S. Tobias, S. Deng, and L. Wojnowski Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4) J. Physiol. Pharmacol. 60 Suppl. 4 2009 111 116
64. J. Yang, N. Wang, J. Li, J. Zhang, and P. Feng Effects of resveratrol on NO secretion stimulated by insulin and its dependence on SIRT1 in high glucose cultured endothelial cells Endocrine 37 2010 365 372
65. G. Arunachalam, H. Yao, I.K. Sundar, S. Caito, and I. Rahman SIRT1 regulates oxidant- and cigarette smoke-induced eNOS acetylation in endothelial cells: role of resveratrol Biochem. Biophys. Res. Commun. 393 2010 66 72
66. P. Gresele, P. Pignatelli, G. Guglielmini, R. Carnevale, A.M. Mezzasoma, and A. Ghiselli Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production J. Nutr. 138 2008 1602 1608
67. S.K. Nicholson, G.A. Tucker, and J.M. Brameld Physiological concentrations of dietary polyphenols regulate vascular endothelial cell expression of genes important in cardiovascular health Br. J. Nutr. 103 2010 1398 1403
68. A.M. El-Mowafy, M. Alkhalaf, and S.M. Jaffal Nongenomic activation of the GC-A enzyme by resveratrol and estradiol downstream from membrane estrogen receptors in human coronary arterial cells Nutr. Metab. Cardiovasc. Dis. 17 2007 508 516 (Pubitemid 47176860)
69. J.R. Klinger The nitric oxide/cGMP signaling pathway in pulmonary hypertension Clin. Chest Med. 28 2007 143 167 (ix) (Pubitemid 46343758)
70. K.J. Pearson, J.A. Baur, K.N. Lewis, L. Peshkin, N.L. Price, and N. Labinskyy Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span Cell Metab. 8 2008 157 168
71. L. Rivera, R. Morón, A. Zarzuelo, and M. Galisteo Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats Biochem. Pharmacol. 77 2009 1053 1063
72. J.-G. Zou, Z.-R. Wang, Y.-Z. Huang, K.-J. Cao, and J.M. Wu Effect of red wine and wine polyphenol resveratrol on endothelial function in hypercholesterolemic rabbits Int. J. Mol. Med. 11 2003 317 320
73. M. Chalopin, A. Tesse, M.C. Martínez, D. Rognan, J.-F. Arnal, and R. Andriantsitohaina Estrogen receptor alpha as a key target of red wine polyphenols action on the endothelium PLoS ONE 5 2010 e8554
74. M. Lagouge, C. Argmann, Z. Gerhart-Hines, H. Meziane, C. Lerin, and F. Daussin Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha Cell. 127 2006 1109 1122 (Pubitemid 44894520)
75. J.A. Baur, K.J. Pearson, N.L. Price, H.A. Jamieson, C. Lerin, and A. Kalra Resveratrol improves health and survival of mice on a high-calorie diet Nature 444 2006 337 342 (Pubitemid 44764104)
76. M.E. Patti, A.J. Butte, S. Crunkhorn, K. Cusi, R. Berria, and S. Kashyap Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1 Proc. Natl. Acad. Sci. U.S.A. 100 2003 8466 8471 (Pubitemid 36842568)
77. V.K. Mootha, C.M. Lindgren, K.-F. Eriksson, A. Subramanian, S. Sihag, and J. Lehar PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes Nat. Genet. 34 2003 267 273 (Pubitemid 36792858)
78. J.T. Rodgers, C. Lerin, W. Haas, S.P. Gygi, B.M. Spiegelman, and P. Puigserver Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1 Nature 434 2005 113 118 (Pubitemid 40349395)
79. C. Cantó, Z. Gerhart-Hines, J.N. Feige, M. Lagouge, L. Noriega, and J.C. Milne AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity Nature 458 2009 1056 1060
80. G.J. Soleas, J. Yan, and D.M. Goldberg Measurement of trans-resveratrol, (+)-catechin, and quercetin in rat and human blood and urine by gas chromatography with mass selective detection Meth. Enzymol. 335 2001 130 145 (Pubitemid 32507233)
81. G.J. Soleas, J. Yan, and D.M. Goldberg Ultrasensitive assay for three polyphenols (catechin, quercetin and resveratrol) and their conjugates in biological fluids utilizing gas chromatography with mass selective detection J. Chromatogr. B. Biomed. Sci. Appl. 757 2001 161 172 (Pubitemid 32424469)
82. D.M. Goldberg, J. Yan, and G.J. Soleas Absorption of three wine-related polyphenols in three different matrices by healthy subjects Clin. Biochem. 36 2003 79 87 (Pubitemid 36126394)
83. D.J. Boocock, G.E.S. Faust, K.R. Patel, A.M. Schinas, V.A. Brown, and M.P. Ducharme Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent Cancer Epidemiol. Biomarkers Prev. 16 2007 1246 1252 (Pubitemid 46984966)
84. M. Vaz-da-Silva, A.I. Loureiro, A. Falcao, T. Nunes, J.-F. Rocha, and C. Fernandes-Lopes Effect of food on the pharmacokinetic profile of trans-resveratrol Int. J. Clin. Pharmacol. Ther. 46 2008 564 570
85. L. Almeida, M. Vaz-da-Silva, A. Falcão, E. Soares, R. Costa, and A.I. Loureiro Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers Mol. Nutr. Food Res. 53 Suppl. 1 2009 S7 15